AbCellera Biologics stockABCL
AbCellera Biologics trades at $11.13, 25.9% below its 52-week high (Sep 30, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +225.4% year to date, +137.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 9, 2026.
Ratings, candles, signals and the screener for ABCL — after you log in
Open the terminalFrequently asked questions about AbCellera Biologics
What is the AbCellera Biologics stock price?
At the close on Nov 5, 2026: $11.13 (−9.36% on the day). 52-week high: $15.02 on Sep 30, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does AbCellera Biologics report earnings?
The next quarterly report is on Nov 9, 2026. Last quarter, earnings per share changed −50% year over year, revenue −76%.
Does AbCellera Biologics pay dividends?
No, AbCellera Biologics does not pay dividends.
Where does AbCellera Biologics trade and how to buy it?
Ticker ABCL, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy AbCellera Biologics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ABCL are in the terminal after you log in.